250 related articles for article (PubMed ID: 25153085)
1. Changes in white matter integrity before conversion from mild cognitive impairment to Alzheimer's disease.
Defrancesco M; Egger K; Marksteiner J; Esterhammer R; Hinterhuber H; Deisenhammer EA; Schocke M
PLoS One; 2014; 9(8):e106062. PubMed ID: 25153085
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
3. Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
van de Mortel LA; Thomas RM; van Wingen GA;
J Alzheimers Dis; 2021; 83(2):705-720. PubMed ID: 34366336
[TBL] [Abstract][Full Text] [Related]
4. Hippocampus-Based Dynamic Functional Connectivity Mapping in the Early Stages of Alzheimer's Disease.
Wang J; Wang P; Jiang Y; Wang Z; Zhang H; Li H; Biswal BB
J Alzheimers Dis; 2022; 85(4):1795-1806. PubMed ID: 34958033
[TBL] [Abstract][Full Text] [Related]
5. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
[TBL] [Abstract][Full Text] [Related]
6. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M
J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639
[TBL] [Abstract][Full Text] [Related]
7. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.
Chételat G; Landeau B; Eustache F; Mézenge F; Viader F; de la Sayette V; Desgranges B; Baron JC
Neuroimage; 2005 Oct; 27(4):934-46. PubMed ID: 15979341
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease.
Wen MC; Ng A; Chander RJ; Au WL; Tan LC; Kandiah N
Parkinsonism Relat Disord; 2015 May; 21(5):483-8. PubMed ID: 25753847
[TBL] [Abstract][Full Text] [Related]
9. Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer's disease.
Kumar A; Singh S; Verma A; Mishra VN
Neurosci Lett; 2018 May; 676():71-77. PubMed ID: 29649488
[TBL] [Abstract][Full Text] [Related]
10. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
[TBL] [Abstract][Full Text] [Related]
11. Structural neuroimaging changes associated with subjective cognitive decline from a clinical sample.
Riverol M; Ríos-Rivera MM; Imaz-Aguayo L; Solis-Barquero SM; Arrondo C; Montoya-Murillo G; Villino-Rodríguez R; García-Eulate R; Domínguez P; Fernández-Seara MA
Neuroimage Clin; 2024; 42():103615. PubMed ID: 38749146
[TBL] [Abstract][Full Text] [Related]
12. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
Risacher SL; Saykin AJ; West JD; Shen L; Firpi HA; McDonald BC;
Curr Alzheimer Res; 2009 Aug; 6(4):347-61. PubMed ID: 19689234
[TBL] [Abstract][Full Text] [Related]
13. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
Dadar M; Manera AL; Ducharme S; Collins DL
Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
[TBL] [Abstract][Full Text] [Related]
14. Profiling heterogeneity of Alzheimer's disease using white-matter impairment factors.
Sui X; Rajapakse JC;
Neuroimage Clin; 2018; 20():1222-1232. PubMed ID: 30412925
[TBL] [Abstract][Full Text] [Related]
15. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance.
Bosch B; Arenaza-Urquijo EM; Rami L; Sala-Llonch R; Junqué C; Solé-Padullés C; Peña-Gómez C; Bargalló N; Molinuevo JL; Bartrés-Faz D
Neurobiol Aging; 2012 Jan; 33(1):61-74. PubMed ID: 20371138
[TBL] [Abstract][Full Text] [Related]
16. Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau.
Tucholka A; Grau-Rivera O; Falcon C; Rami L; Sánchez-Valle R; Lladó A; Gispert JD; Molinuevo JL;
J Alzheimers Dis; 2018; 61(4):1575-1587. PubMed ID: 29376852
[TBL] [Abstract][Full Text] [Related]
17. Gray & white matter tissue contrast differentiates Mild Cognitive Impairment converters from non-converters.
Jefferson AL; Gifford KA; Damon S; Chapman GW; Liu D; Sparling J; Dobromyslin V; Salat D;
Brain Imaging Behav; 2015 Jun; 9(2):141-8. PubMed ID: 24493370
[TBL] [Abstract][Full Text] [Related]
18. A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up.
Scola E; Bozzali M; Agosta F; Magnani G; Franceschi M; Sormani MP; Cercignani M; Pagani E; Falautano M; Filippi M; Falini A
J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):798-805. PubMed ID: 20392973
[TBL] [Abstract][Full Text] [Related]
19. Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD.
Spulber G; Niskanen E; Macdonald S; Kivipelto M; Padilla DF; Julkunen V; Hallikainen M; Vanninen R; Wahlund LO; Soininen H
Curr Alzheimer Res; 2012 May; 9(4):516-24. PubMed ID: 22191564
[TBL] [Abstract][Full Text] [Related]
20. Brain-Cognition Associations in Older Patients With Remitted Major Depressive Disorder or Mild Cognitive Impairment: A Multivariate Analysis of Gray and White Matter Integrity.
Marawi T; Zhukovsky P; Rashidi-Ranjbar N; Bowie CR; Brooks H; Fischer CE; Flint AJ; Herrmann N; Mah L; Pollock BG; Rajji TK; Tartaglia MC; Voineskos AN; Mulsant BH;
Biol Psychiatry; 2023 Dec; 94(12):913-923. PubMed ID: 37271418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
